GSK now expects 2025 revenue growth of six to seven percent, double the lower end of its previous forecast

GSK now expects 2025 revenue growth of six to seven percent, double the lower end of its previous forecast

 JUSTIN TALLIS

British pharmaceutical group GSK on Wednesday raised its full-year outlook after strong sales growth in its third quarter, brushing off the potential impact of US tariffs.  

Profit after tax stood at £2 billion ($2.7 billion) in the quarter, compared with a net loss of £58 million one year earlier linked to hefty US lawsuit settlements.

Originally published on doc.afp.com, part of the BLOX Digital Content Exchange.

Tags

Recommended for you